GPR55 and ovarian carcinoma: Additionally, increased levels of the proposed endogenous GPR55 ligand LPI [40], have been found in plasma and/or ascites from patients with colon [17] or ovarian cancer [41, 42], when compared with healthy subjects, or with women with non-cancerous pathologies.